Annual Shareholders Equity
$16.66 M
-$111.07 M-86.96%
31 December 2023
Summary:
Syros Pharmaceuticals annual stockholders equity is currently $16.66 million, with the most recent change of -$111.07 million (-86.96%) on 31 December 2023. During the last 3 years, it has fallen by -$73.89 million (-81.60%). SYRS annual shareholders equity is now -86.96% below its all-time high of $127.74 million, reached on 31 December 2022.SYRS Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
-$11.12 M
-$4.77 M-75.11%
30 September 2024
Summary:
Syros Pharmaceuticals quarterly stockholders equity is currently -$11.12 million, with the most recent change of -$4.77 million (-75.11%) on 30 September 2024. Over the past year, it has dropped by -$47.42 million (-130.64%). SYRS quarterly shareholders equity is now -107.42% below its all-time high of $149.88 million, reached on 31 March 2021.SYRS Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SYRS Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -87.0% | -130.6% |
| 3 y3 years | -81.6% | -110.5% |
| 5 y5 years | -78.8% | -111.8% |
SYRS Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -87.0% | at low | -108.6% | at low |
| 5 y | 5 years | -87.0% | at low | -107.4% | at low |
| alltime | all time | -87.0% | at low | -107.4% | at low |
Syros Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$11.12 M(+75.1%) |
| June 2024 | - | -$6.35 M(-142.2%) |
| Mar 2024 | - | $15.06 M(-9.6%) |
| Dec 2023 | $16.66 M(-87.0%) | $16.66 M(-54.1%) |
| Sept 2023 | - | $36.30 M(-50.4%) |
| June 2023 | - | $73.24 M(-31.4%) |
| Mar 2023 | - | $106.75 M(-16.4%) |
| Dec 2022 | $127.74 M(+49.9%) | $127.74 M(-1.1%) |
| Sept 2022 | - | $129.17 M(+316.4%) |
| June 2022 | - | $31.02 M(-50.6%) |
| Mar 2022 | - | $62.74 M(-26.4%) |
| Dec 2021 | $85.22 M(-5.9%) | $85.22 M(-19.7%) |
| Sept 2021 | - | $106.06 M(-18.4%) |
| June 2021 | - | $129.98 M(-13.3%) |
| Mar 2021 | - | $149.88 M(+65.5%) |
| Dec 2020 | $90.55 M | $90.55 M(+97.1%) |
| Sept 2020 | - | $45.94 M(-26.4%) |
| June 2020 | - | $62.41 M(-18.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $76.54 M(-3.3%) |
| Dec 2019 | $79.18 M(+0.8%) | $79.18 M(-16.3%) |
| Sept 2019 | - | $94.57 M(-15.5%) |
| June 2019 | - | $111.92 M(+74.8%) |
| Mar 2019 | - | $64.02 M(-18.5%) |
| Dec 2018 | $78.59 M(+20.3%) | $78.59 M(-17.1%) |
| Sept 2018 | - | $94.84 M(-12.8%) |
| June 2018 | - | $108.71 M(+4.0%) |
| Mar 2018 | - | $104.50 M(+60.0%) |
| Dec 2017 | $65.32 M(-19.0%) | $65.32 M(-16.9%) |
| Sept 2017 | - | $78.59 M(-13.7%) |
| June 2017 | - | $91.08 M(+29.9%) |
| Mar 2017 | - | $70.14 M(-13.0%) |
| Dec 2016 | $80.60 M(+136.7%) | $80.60 M(-11.2%) |
| Sept 2016 | - | $90.78 M(+70.0%) |
| June 2016 | - | $53.39 M(-16.5%) |
| Mar 2016 | - | $63.92 M(+87.7%) |
| Dec 2015 | $34.05 M(-43.5%) | $34.05 M |
| Dec 2014 | $60.24 M | - |
FAQ
- What is Syros Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Syros Pharmaceuticals?
- What is Syros Pharmaceuticals annual shareholders equity year-on-year change?
- What is Syros Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Syros Pharmaceuticals?
- What is Syros Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Syros Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of SYRS is $16.66 M
What is the all time high annual shareholders equity for Syros Pharmaceuticals?
Syros Pharmaceuticals all-time high annual stockholders equity is $127.74 M
What is Syros Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, SYRS annual stockholders equity has changed by -$111.07 M (-86.96%)
What is Syros Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of SYRS is -$11.12 M
What is the all time high quarterly shareholders equity for Syros Pharmaceuticals?
Syros Pharmaceuticals all-time high quarterly stockholders equity is $149.88 M
What is Syros Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, SYRS quarterly stockholders equity has changed by -$47.42 M (-130.64%)